Welcome : Guest

Laboratory Corporation of America Holdings (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Laboratory Corporation of America Holdings, which is principally involved in providing Clinical Laboratory Services. Illustrated with 116 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-00974
Price: $3500
Company Type: Public
Pages: 120
Date: November 2015
Market Data Tables: 116

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Laboratory Corporation of America Holding’s Sales by Product Segment Worldwide (2013-2014) in Percentage for Clinical Diagnostics Laboratory (Core Testing and Genomic and Esoteric Testing) and Others......4
Clinical Laboratories......5
Table 2: Clinical Laboratory Market by Category in the US (2015) - Percentage Share Breakdown by Value for Hospital Inpatient, Hospital Outpatient, and Outside the Hospital......5
Table 3: Clinical Laboratory Market by Payer Type in the US (2014) - Percentage Share Breakdown by Value for Health Maintenance Organizations (HMOs), Medicare, Patient Self-Pay and Third Party payer......6
Table 4: Clinical Labs Market by Segment in the US (2014) - Percentage Share Breakdown by Value Sales for Anatomic Pathology, Clinical Pathology, Cytology, Drugs of Abuse (DOA) and Esoteric/Molecular Pathology......7
Clinical Laboratory Testing Market......8
Table 5: Clinical Testing Lab Market by Category in the US (2014) - Percentage Share Breakdown by Volume for Hospital Labs, Independent Clinical Labs, Physician Office Labs and Others......8
Table 6: Clinical Laboratory Testing Market by Category in the US (2014) – Percentage Share Breakdown by Value Sales for Laboratory Corporation of America Holdings, Quest Medical, Inc., Physician Office, Hospital Affiliated, and Others......9
Lab Products & Services......10
Table 7: Lab Products & Services Market by Category Worldwide (2015) – Percentage Share Breakdown by Value for Academia, Food & Beverage, Chemicals and Other, and Pharma/Bio tech......10
Clinical Diagnostics......11
Table 8: Clinical NGS Based Diagnostics Test market by Segment Worldwide (2015)-Percentage Share Breakdown by Value for Exome, Targeted Panels and Others......11
Table 9: Clinical Diagnostics Market by Category in the US (2015) - Percentage Share Breakdown by Value for Hospital-Based Labs, Independent Clinical Labs, Labcorp, Physician-Office Labs, and Quest......12
Diagnostics......13
Table 10: Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs, Physician Office Labs and Others......13
Table 11: Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs, Physician Office Labs and Others......14
Diagnostic Testing......15
Table 12: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......15
Table 13: Diagnostic Testing Market by Segment in the US (2014) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......16
Table 14: Diagnostic Testing Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......17
Table 15: Diagnostic Testing Sales by Category in the US (2014) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......18
Table 16: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......19
Table 17: Hospital Diagnostics Testing Services Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Outpatient, and Inpatient......20
Table 18: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......21
Table 19: Genomic Technology (Academic, Government, Applied Markets, Biopharma, Diagnostic Labs) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......22
Table 20: Genomic Technology for Diagnostic Labs Sector by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......23
Imaging Services......24
Table 21: Global Imaging Market by Type (2014) - Percentage Market Share Breakdown by Value Sales for Computed Tomography (CT), Diagnostic X-Ray, Interventional X-Ray, Magnetic Resonance Imaging (MRI), Nuclear Medicine, Ultrasound, and Women's Health Care......24
Genetic Testing......25
Table 22: Genetic Test Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Exome, Mendeliome, Small Panel, and Whole Genome......25
Table 23: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Cancer, Neurology, Pediatric Development, and Others......26
Table 24: Genetic Testing Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Detection, Predisposition, Treatment Selection, Monitoring, and Others......27
Blood Screening Tests......28
Table 25: Blood Screening Test Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Commercial West Nile Virus, Tigris/Spare Parts to Chiron at Cost, Ultrio/Procleix Blood Screening, and Others......28
Table 26: Gram-Negative Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......29
Table 27: Gram-Positive Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......30
Hospital Lab Tests......31
Table 28: Hospital Lab Test Sales by Source of Payment in the US (2015) - Percentage Market Share Breakdown by Value for Fee for Service, Medicaid, Medicare, and Others......31
Table 29: Lab Test Revenue in Hospitals by Category in the US (2014) - Percentage Market Share Breakdown by Value for Capitated, Fee for Service, Medicaid, Medicare Part A, Medicare Part B, Out of Pocket and Others......32
Oncology Genomics......33
Table 30: Oncology Genomics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......33
Table 31: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Us, and Others......34
Table 32: Oncology Genomics Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......35
Clinical Oncology......36
Table 33: Clinical Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......36
HIV Regimens for Experienced Patients......37
Table 34: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others (Includes NNRTIs)......37
Table 35: HIV Regimens for Experienced Patients by Segment in the US (2014) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......38
HIV Regimens for New Start Patients......39
Table 36: HIV Regimens for New Start Patients by Segment in European Union (2014) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......39
Table 37: HIV Regimens for New Start Patients by Segment in the US (2014) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......40
In Vitro Diagnostics (IVD)......41
Table 38: Global IVD Market (2014) in US$ Million......41
Table 39: In Vitro Diagnostics (IVD) Market by Region Worldwide (2015) - Percentage Breakdown by Value for Europe, Japan, US, and Rest of World......42
Table 40: Clinical In-Vitro Diagnostics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan, United States, and Rest of World......43
Table 41: In-Vitro Diagnostics (IVD) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value for Europe, United States and Others......44
Table 42: In Vitro Diagnostics (IVD) Market by Region in Europe (2014) - Percentage Share Breakdown by Value Sales for Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain, Switzerland, UK, and Rest of the Europe......45
Table 43: In Vitro Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Anatomic Pathology, Clinical Chemistry, Diabetes Monitoring, Immunoassay, Molecular Diagnostics, Point of Care, and Others......46
Table 44: In-Vitro Diagnostic Products Market by Segment in China (2014) - Percentage Share Breakdown by Value for Blood Testing, Cellular Analysis, Clinical Chemistry, Diabetes Testing, Immunoassay, Microbiology, Molecular Diagnostics, and Pathology......47
Table 45: In Vitro Diagnostics (IVD) Laboratory Market by Segment in France (2014) - Percentage Share Breakdown by Value Sales for Instruments, and Reagents......48
Table 46: In Vitro Diagnostics (IVD) Market by Product Category Worldwide (2015) - Percentage Breakdown by Value for Instrumentation, and Reagents......49
Table 47: In Vitro Diagnostics (IVD) Market by Category in France (2014) - Percentage Share Breakdown by Value Sales for Laboratory in Vitro Diagnostics, and Self-Monitoring of Blood Glucose......50
Table 48: In Vitro Diagnostics (IVD) Market by Technology Worldwide (2014) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, Flow Cytometry, HBGM, Immunoassay, MDx, and Others......51
Table 49: In Vitro Diagnostics (IVD) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Biochemistry, Hematology and Flow, Hemostasis, Histology and Cytology, Immunoassays, Microbiology, Molecular, and Others......52
Table 50: In-Vitro Diagnostics (IVD) Manufacturer Market by Technology Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, HBGM (Home Blood Glucose Monitoring), Immunoassay, MDX (Molecular Diagnostics) and Others......53
Table 51: In Vitro Diagnostics (IVD) Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Cancer, Cardiovascular (CV), Infectious Disease, and Others......54
Table 52: In Vitro Diagnostics (IVD) Market by Disease Type Worldwide (2015) - Percentage Breakdown by Value for Cancers, Cardio-Vascular Diseases, Infective Diseases, and Others......55
Table 53: In-Vitro Diagnostics Market by Product Worldwide (2014) - Percentage Share Breakdown by Value for Clinical Chemistry Product, Hematology/Coagulation, Immunoassay Systems and Others......56
Table 54: Global In Vitro Diagnostics (IVD) Market by Area (2014) - Percentage Share Breakdown by Value Sales for Clinical Chemistry, Flow Cytometry, Hematology & Blood, Histology & Cytology, Immunoassays, Microbiology & Virology, Molecular Diagnostics and Point-of-Care Testing......57
In Vitro Diagnostics (IVD) Laboratory Services......58
Table 55: In Vitro Diagnostics (IVD) Laboratory Services Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Hospital Labs, Independent Labs, Physician Office Labs, and Others......58
Table 56: In-Vitro Diagnostics (IVD) Laboratory Services Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Hospital Labs, Physician Office Labs, Other Independent Labs and Others......59
Table 57: In Vitro Diagnostics (IVD) Reagents Market by Category in France (2014) - Percentage Share Breakdown by Value Sales for Biochemistry, Genetic Tests, Haematology, Immunochemistry, Infectious Immunology, and Microbiology......60
Table 58: In Vitro Diagnostics (IVD) Laboratory Market by Customer in France (2014) - Percentage Share Breakdown by Value Sales for Etablissement Français du Sang (EFS), Private Laboratories, Public and Private Hospitals, and Others......61
Molecular Diagnostic Genetics Laboratories......62
Table 59: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2014) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......62
Molecular Diagnostics Laboratories......63
Table 60: Molecular Diagnostics Test Market by Type in Europe (2014) - Percentage Share Breakdown by Volume for Chlamydia Trachomatis (CT) - Neisseria Gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-Resistant Staphylococcus Aureus (MRSA) and Others......63
Table 61: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2014) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......64
Table 62: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2014) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......65
Table 63: Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market by Type in the US (2014) - Percentage Share Breakdown by Value Sales for Chromogenic Media, Conventional Media, GeneXpert, GneOhm, LightCycler and Molecular Diagnostics Laboratory-Developed Test (MDX LDT)......66
Molecular Diagnostics Infectious Diseases......67
Table 64: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), methicillin-resistant S. aureus (MRSA), Viral Load, and Others......67
Table 65: Molecular Infectious Disease Market by Panel Worldwide (2014) – Percentage Share Breakdown by Value Sales for BSI +/- (Sepsis), CSF, Enteric (GI), Fungal (Candida), HCV Genotyping, Respiratory, and STI......68
Molecular Cystic Fibrosis (CF) Testing......69
Table 66: Molecular Cystic Fibrosis (CF) Testing Market by Assay in the US (2014) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis Genotyping, eSensor® Cystic Fibrosis, InPlex® Cystic Fibrosis (CF), Laboratory Developed Tests and xTAG® Cystic Fibrosis......69
Molecular Diagnostics......70
Table 67: Molecular Diagnostics (MoDx) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......70
Table 68: Global Molecular Diagnostics (MDx) Market by Region (2014) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......71
Table 69: Molecular Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......72
Table 70: Molecular Diagnostic Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......73
Table 71: Molecular Diagnostics Market by Segment in the US (2014) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......74
Table 72: Molecular Diagnostics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......75
Table 73: Molecular Diagnostics Market by Application Worldwide (2015)-Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......76
Table 74: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2014) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......77
Table 75: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......78
Table 76: Molecular Diagnostics (MDx) Market by Technology Worldwide (2014) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......79
Table 77: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......80
Table 78: Molecular Diagnostics Lab Market by Test Complexity in the US (2015)-Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......81
Table 79: Molecular Diagnostics Lab Market by Test Type in the US (2015)-Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......82
Pathogen Testing......83
Table 80: Pathogen Testing Market by Segment Worldwide (2014) - Percentage Share Breakdown by Volume for Escherichia Coli, Listeria, Salmonella, and Others......83
Table 81: Pathogen Testing Market by Category in North America (2014) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Molecular, and Traditional......84
Table 82: Pathogen Testing Market by Category in European Union (EU) (2014) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Molecular, and Traditional......85
Table 83: Pathogen Testing Market by Category in Asia (2014) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Convenience, Molecular, and Traditional......86
Table 84: Pathogen Testing Market by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Culture, Immunochemical, and Molecular......87
Table 85: Pathology Market by Service Benefit in Australia (2014) - Percentage Share Breakdown by Value Sales for Esoteric Services and Routine Services......88
Table 86: Pathology Market by Service in Australia (2014) - Percentage Share Breakdown by Value Sales for Esoteric Services and Routine Services......89
Clinical Laboratories......90
Table 87: Market Shares of Leading Clinical Laboratories in the US (2015) - Percentage Breakdown by Value Sales for Laboratory Corporation of America Holdings, Physician Office Partners, Inc., Quest Diagnostics Incorporated, and Others......90
Clinical Testing......91
Table 88: Market Shares of Leading Clinical Testing Service Providers Worldwide (2015) - Percentage Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics, Inc., and Others......91
Table 89: Market Shares of Leading Clinical Testing Service Providers in Japan (2015) - Percentage Breakdown by Value for BML, Inc., Falco Biosystems Ltd., Mitsubishi Chemical Medience Corporation, Special Reference Laboratories, Inc., and Others......92
Table 90: Market Shares of Leading Clinical Supply Solutions Providers Worldwide (2015)-Percentage Share Breakdown by Value for Fisher Clinic, Alamc, Catalent, Inc. and Other......93
Diagnostic Testing......94
Table 91: Market Shares of Leading Diagnostic Testing Companies in the US (2015)-Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......94
Diagnostic Ultrasound......95
Table 92: Market Shares of Leading Diagnostic Ultrasound Manufacturers by Value Sales in Japan (2014) - Percentage Share Breakdown For GE Healthcare, Hitachi Medical Corporation, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, and Others......95
Diagnostic Imaging Services......96
Table 93: Market Shares of Leading Diagnostic Imaging Service Providers by Value Sales in Australia (2014) - Percentage Breakdown for I-MED Radiology Network, Sonic Healthcare Limited, Primary, Independent Diagnostic Services, and Public Hospitals......96
Cancer Genetic Diagnostics Services......97
Table 94: Market Shares of Leading Cancer Genetic Diagnostics Reference Laboratory Services in the US (2015) - Percentage Breakdown by Value Sales for ARUP Laboratories, Clarient Diagnostic Services, Inc., Laboratory Corporation of America Holdings, Mayo Medical Laboratories, NeoGenomics, Inc., Quest Diagnostics Incorporated and AmeriPath, Inc., and Others......97
In Vitro Diagnostics (IVD)......98
Table 95: Market Shares of Leading In Vitro Diagnostics (IVD) Laboratory Service Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Quest Diagnostics, Inc. (DGX), Laboratory Corporation of America Holdings (LH), Bio-Reference Laboratories, Inc. (BRLI), Myriad Genetics, Inc. (MYGN), and Others......98
Table 96: Market Shares of Leading In Vitro Diagnostics (IVDs) Companies in the US (2014) - Percentage Share Breakdown by Value for Abbott Laboratories, BioMérieux, Danaher Corporation, The, F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, and Others......99
Table 97: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers in China (2015) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Mindray Medical International Limited, Roche Holdings, Inc., and Others......100
Table 98: Market Shares of Leading In Vitro Diagnostics (IVD) Instrumentation (Mid to High throughput Analyzer) Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Hitachi, Ltd., Invetech, KMC Systems Inc., Stratec Biomedical AG, Tecan Group Ltd., and Others......101
Table 99: Market Shares of Leading In-Vitro Diagnostics (IVD) Laboratory Service Providers Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bio-Reference Laboratories, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Quest Diagnostics, Inc. and Others......102
Table 100: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Alere, Inc., Danaher Corporation, LifeScan, Inc., Roche Holdings, Inc., System Industrie Electronic GmbH, Thermo Fisher Scientific Inc. and Others......103
Molecular Diagnostics......104
Table 101: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......104
Table 102: Market Shares of Leading Molecular Diagnostics Providers Worldwide (2015) - Percentage Breakdown by Value for Abbott, Becton Dickinson, BioMerieux, Cepheid Inc, Hologic Corporation, Novartis International AG, Qiagen N.V., Roche Holding AG, Siemens AG, and Others......105
Table 103: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......106
Table 104: Market Shares of Leading Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Testing Providers in the US (2014) - Percentage Breakdown by Value Sales for Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gen-Probe, Inc. and Qiagen NV......107
Table 105: Market Shares of Leading Molecular Clostridium Difficile (C. Diff) Testing Providers the US (2014) - Percentage Breakdown by Value Sales for Becton, Dickinson and Company, Cepheid, Inc., Hologic Gen-Probe, Inc., Meridian Bioscience, Inc. and Others......108
Blood Screening Tests......109
Table 106: Market Shares of Leading Blood Screening Test Companies by Value Sales Worldwide (2015) - Percentage Breakdown for F. Hoffmann-La Roche AG, Gen-Probe, Inc., and Others......109
Independent Laboratory Services......110
Table 107: Market Shares of Leading Independent Clinical Laboratory Service Providers in the US (2015) - Percentage Breakdown by Value Sales for Laboratory Corporation of America Holdings, Nichelabs, LLC, Quest Diagnostics Incorporated, and Others......110
Table 108: Market Shares of Leading Medicare Independent Laboratory Service Providers in the US (2015) - Percentage Breakdown by Value for Laboratory Corporation of America Holdings, Millennium Health, LLC, Quest Diagnostics, and Others......111
Pathology Services......112
Table 109: Market Shares of Leading Pathology Companies in Australia (2014) - Percentage Breakdown by Value Sales for Healthscope Corporate Pathology, Primary Health Care Limited, Sonic Healthcare Limited and Others......112
Table 110: Market Shares of Leading Anatomic Pathology Service Providers Worldwide (2014) - Percentage Breakdown by Test Volume for Hospitals, Independent Labs, Kaiser Permanente, Laboratory Corporation of America Holdings, Physician Office Labs, Quest Diagnostics Incorporated and Others......113
STD Testing Services......114
Table 111: Market Shares of Leading STD Testing Companies by Value Sales Worldwide (2015) - Percentage Breakdown for Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gen-Probe, Inc., and Others......114
Table 112: Laboratory Corporation of America Holding's Revenue by Test Type in the US (2014) - Percentage Market Share Breakdown by Value for Genomic and Esoteric Testing, Routine Testing and Others......115
Table 113: Laboratory Corporation of America Holding's Revenue by Test Type in the US (2014) - Percentage Market Share Breakdown by Volume for Genomic and Esoteric Testing, Routine Testing and Others......116
Table 114: Laboratory Corporation of America Holding's Revenue by Payer in the US (2014) - Percentage Market Share Breakdown by Volume for Commercial Clients, Managed Care, Medicare and Medicaid and Private Patients......117
Table 115: Laboratory Corporation’s of America Holding’s Sales by Product Segment Worldwide (2013) in Percentage for Clinical Laboratory Diagnostics and Others......118
Table 116: Laboratory Corporation’s of America Holding’s Sales by Product Category Worldwide (2013) in Percentage for Clinical Diagnostics Laboratory (Core Testing and Genomic and Esoteric Testing) and Others......119